US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist

4.450
-0.030-0.67%

Close May 3 16:00 ET

4.500
+0.050+1.12%

Post 19:59 ET

918.17MMarket Cap-3771P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

41.22%-95.14M

62.61%-8.92M

38.67%-19.9M

32.22%-18.81M

38.93%-47.51M

-13.85%-161.85M

26.53%-23.85M

-39.39%-32.44M

-9.23%-27.76M

-27.52%-77.8M

Net income from continuing operations

8.33%-226.54M

13.71%-61.73M

14.98%-36.15M

-27.98%-75.33M

28.12%-53.33M

-34.26%-247.12M

-302.39%-71.54M

27.69%-42.52M

-36.25%-58.86M

-15.42%-74.2M

Operating gains losses

--29.02M

--0

----

Depreciation and amortization

15.17%1.66M

6.82%423K

7.97%420K

21.49%407K

27.76%405K

84.94%1.44M

131.58%396K

69.87%389K

68.34%335K

78.09%317K

Other non cash items

-13.65%86.23M

-55.42%19.94M

20.22%22.11M

33.85%23.72M

7.63%20.45M

84.21%99.85M

151.81%44.73M

33.52%18.39M

52.29%17.72M

72.33%19M

Change In working capital

45.03%-32.4M

253.94%18.1M

9.64%-16.2M

-301.58%-6.64M

15.04%-27.66M

-825.57%-58.95M

-179.66%-11.76M

-311.17%-17.93M

293.77%3.3M

-142.50%-32.56M

-Change in receivables

71.61%-6.1M

61.14%-2.97M

358.96%3.84M

-69.73%-8.99M

128.65%2.02M

-3.14%-21.47M

-136.04%-7.64M

-206.23%-1.48M

71.71%-5.3M

-2,600.38%-7.05M

-Change in inventory

88.33%-1.45M

178.19%907K

7.84%-3.39M

112.41%898K

137.01%131K

-41.70%-12.42M

45.72%-1.16M

3.85%-3.67M

-52.77%-7.24M

-118.37%-354K

-Change in prepaid assets

-164.03%-6.82M

148.93%710K

-7,273.17%-6.05M

-16.30%1.06M

-9.78%-2.55M

63.90%-2.58M

60.73%-1.45M

97.61%-82K

-87.06%1.27M

76.45%-2.32M

-Change in payables and accrued expense

24.84%-16.81M

1,964.17%19.87M

27.80%-9.26M

-101.30%-188K

-18.85%-27.23M

-151.31%-22.36M

-104.63%-1.07M

-189.82%-12.83M

22.56%14.45M

-316.81%-22.91M

-Change in other working capital

-1,028.44%-1.23M

4.34%-419K

-1,041.26%-1.35M

413.51%570K

-146.67%-35K

-108.50%-109K

-153.03%-438K

164.81%143K

-25.00%111K

-70.59%75K

Cash from discontinued investing activities

Operating cash flow

41.22%-95.14M

62.61%-8.92M

38.67%-19.9M

32.22%-18.81M

38.93%-47.51M

-13.85%-161.85M

26.53%-23.85M

-39.39%-32.44M

-9.23%-27.76M

-27.52%-77.8M

Investing cash flow

Cash flow from continuing investing activities

-2.54%-131.5M

-136.87%-28.47M

133.24%23.12M

80.46%-19.04M

-178.41%-107.11M

-911.43%-128.24M

794.38%77.22M

-997.68%-69.54M

-2,263.37%-97.44M

-362.20%-38.47M

Net PPE purchase and sale

-60.47%-2.17M

-5.32%-554K

-464.00%-987K

-91.39%-467K

60.59%-160K

43.35%-1.35M

52.53%-526K

52.05%-175K

69.99%-244K

-310.10%-406K

Net investment purchase and sale

-1.93%-129.33M

-135.91%-27.92M

134.75%24.11M

80.90%-18.57M

-180.96%-106.95M

-797.60%-126.89M

876.48%77.74M

-955.13%-69.37M

-1,927.99%-97.19M

-357.69%-38.07M

Cash from discontinued investing activities

Investing cash flow

-2.54%-131.5M

-136.87%-28.47M

133.24%23.12M

80.46%-19.04M

-178.41%-107.11M

-911.43%-128.24M

794.38%77.22M

-997.68%-69.54M

-2,263.37%-97.44M

-362.20%-38.47M

Financing cash flow

Cash flow from continuing financing activities

-63.10%32.49M

-175.57%-3.17M

-98.40%1.23M

19,870.07%29.36M

-30.98%5.08M

-75.53%88.03M

-98.79%4.2M

1,498.09%76.33M

-96.79%147K

153.66%7.36M

Net issuance payments of debt

-20.10%58.38M

---1.17M

--0

----

-75.13%73.07M

--0

--73.07M

----

Net common stock issuance

80.00%342K

----

-99.62%190K

----

Proceeds from stock option exercised by employees

-43.52%8.34M

-104.44%-178K

-54.29%1.49M

1,229.25%1.95M

-30.98%5.08M

-6.16%14.77M

15.07%4.01M

-31.89%3.25M

-96.79%147K

153.66%7.36M

Net other financing activities

---34.58M

---2.17M

---262K

----

Cash from discontinued financing activities

Financing cash flow

-63.10%32.49M

-175.57%-3.17M

-98.40%1.23M

19,870.07%29.36M

-30.98%5.08M

-75.53%88.03M

-98.79%4.2M

1,498.09%76.33M

-96.79%147K

153.66%7.36M

Net cash flow

Beginning cash position

-39.69%306.24M

-38.60%152.49M

-46.07%147.79M

-60.74%156.6M

-39.69%306.24M

85.07%507.73M

21.80%248.34M

27.65%274.02M

72.73%398.86M

85.07%507.73M

Current changes in cash

3.91%-194.15M

-170.47%-40.56M

117.33%4.45M

93.21%-8.49M

-37.30%-149.54M

-186.60%-202.06M

-81.05%57.57M

-138.65%-25.66M

-665.62%-125.05M

-150.74%-108.92M

Effect of exchange rate changes

-36.04%362K

57.70%522K

1,907.14%253K

-251.67%-317K

-340.00%-96K

697.18%566K

16,450.00%331K

12.50%-14K

145.88%209K

--40K

End cash Position

-63.28%112.45M

-38.60%152.49M

-46.07%147.79M

-60.74%156.6M

-39.69%306.24M

21.80%248.34M

27.65%274.02M

72.73%398.86M

Free cash flow

40.37%-97.31M

61.14%-9.47M

35.98%-20.88M

31.14%-19.28M

39.04%-47.67M

-12.91%-163.2M

27.38%-24.38M

-37.98%-32.62M

-6.78%-28M

-27.98%-78.21M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	41.22%-95.14M	62.61%-8.92M	38.67%-19.9M	32.22%-18.81M	38.93%-47.51M	-13.85%-161.85M	26.53%-23.85M	-39.39%-32.44M	-9.23%-27.76M	-27.52%-77.8M
Net income from continuing operations	8.33%-226.54M	13.71%-61.73M	14.98%-36.15M	-27.98%-75.33M	28.12%-53.33M	-34.26%-247.12M	-302.39%-71.54M	27.69%-42.52M	-36.25%-58.86M	-15.42%-74.2M
Operating gains losses	--29.02M	--0	--0	----	----	----	----	----	----	----
Depreciation and amortization	15.17%1.66M	6.82%423K	7.97%420K	21.49%407K	27.76%405K	84.94%1.44M	131.58%396K	69.87%389K	68.34%335K	78.09%317K
Other non cash items	-13.65%86.23M	-55.42%19.94M	20.22%22.11M	33.85%23.72M	7.63%20.45M	84.21%99.85M	151.81%44.73M	33.52%18.39M	52.29%17.72M	72.33%19M
Change In working capital	45.03%-32.4M	253.94%18.1M	9.64%-16.2M	-301.58%-6.64M	15.04%-27.66M	-825.57%-58.95M	-179.66%-11.76M	-311.17%-17.93M	293.77%3.3M	-142.50%-32.56M
-Change in receivables	71.61%-6.1M	61.14%-2.97M	358.96%3.84M	-69.73%-8.99M	128.65%2.02M	-3.14%-21.47M	-136.04%-7.64M	-206.23%-1.48M	71.71%-5.3M	-2,600.38%-7.05M
-Change in inventory	88.33%-1.45M	178.19%907K	7.84%-3.39M	112.41%898K	137.01%131K	-41.70%-12.42M	45.72%-1.16M	3.85%-3.67M	-52.77%-7.24M	-118.37%-354K
-Change in prepaid assets	-164.03%-6.82M	148.93%710K	-7,273.17%-6.05M	-16.30%1.06M	-9.78%-2.55M	63.90%-2.58M	60.73%-1.45M	97.61%-82K	-87.06%1.27M	76.45%-2.32M
-Change in payables and accrued expense	24.84%-16.81M	1,964.17%19.87M	27.80%-9.26M	-101.30%-188K	-18.85%-27.23M	-151.31%-22.36M	-104.63%-1.07M	-189.82%-12.83M	22.56%14.45M	-316.81%-22.91M
-Change in other working capital	-1,028.44%-1.23M	4.34%-419K	-1,041.26%-1.35M	413.51%570K	-146.67%-35K	-108.50%-109K	-153.03%-438K	164.81%143K	-25.00%111K	-70.59%75K
Cash from discontinued investing activities
Operating cash flow	41.22%-95.14M	62.61%-8.92M	38.67%-19.9M	32.22%-18.81M	38.93%-47.51M	-13.85%-161.85M	26.53%-23.85M	-39.39%-32.44M	-9.23%-27.76M	-27.52%-77.8M
Investing cash flow
Cash flow from continuing investing activities	-2.54%-131.5M	-136.87%-28.47M	133.24%23.12M	80.46%-19.04M	-178.41%-107.11M	-911.43%-128.24M	794.38%77.22M	-997.68%-69.54M	-2,263.37%-97.44M	-362.20%-38.47M
Net PPE purchase and sale	-60.47%-2.17M	-5.32%-554K	-464.00%-987K	-91.39%-467K	60.59%-160K	43.35%-1.35M	52.53%-526K	52.05%-175K	69.99%-244K	-310.10%-406K
Net investment purchase and sale	-1.93%-129.33M	-135.91%-27.92M	134.75%24.11M	80.90%-18.57M	-180.96%-106.95M	-797.60%-126.89M	876.48%77.74M	-955.13%-69.37M	-1,927.99%-97.19M	-357.69%-38.07M
Cash from discontinued investing activities
Investing cash flow	-2.54%-131.5M	-136.87%-28.47M	133.24%23.12M	80.46%-19.04M	-178.41%-107.11M	-911.43%-128.24M	794.38%77.22M	-997.68%-69.54M	-2,263.37%-97.44M	-362.20%-38.47M
Financing cash flow
Cash flow from continuing financing activities	-63.10%32.49M	-175.57%-3.17M	-98.40%1.23M	19,870.07%29.36M	-30.98%5.08M	-75.53%88.03M	-98.79%4.2M	1,498.09%76.33M	-96.79%147K	153.66%7.36M
Net issuance payments of debt	-20.10%58.38M	---1.17M	--0	----	----	-75.13%73.07M	--0	--73.07M	----	----
Net common stock issuance	80.00%342K	----	----	----	----	-99.62%190K	----	----	----	----
Proceeds from stock option exercised by employees	-43.52%8.34M	-104.44%-178K	-54.29%1.49M	1,229.25%1.95M	-30.98%5.08M	-6.16%14.77M	15.07%4.01M	-31.89%3.25M	-96.79%147K	153.66%7.36M
Net other financing activities	---34.58M	---2.17M	---262K	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-63.10%32.49M	-175.57%-3.17M	-98.40%1.23M	19,870.07%29.36M	-30.98%5.08M	-75.53%88.03M	-98.79%4.2M	1,498.09%76.33M	-96.79%147K	153.66%7.36M
Net cash flow
Beginning cash position	-39.69%306.24M	-38.60%152.49M	-46.07%147.79M	-60.74%156.6M	-39.69%306.24M	85.07%507.73M	21.80%248.34M	27.65%274.02M	72.73%398.86M	85.07%507.73M
Current changes in cash	3.91%-194.15M	-170.47%-40.56M	117.33%4.45M	93.21%-8.49M	-37.30%-149.54M	-186.60%-202.06M	-81.05%57.57M	-138.65%-25.66M	-665.62%-125.05M	-150.74%-108.92M
Effect of exchange rate changes	-36.04%362K	57.70%522K	1,907.14%253K	-251.67%-317K	-340.00%-96K	697.18%566K	16,450.00%331K	12.50%-14K	145.88%209K	--40K
End cash Position	-63.28%112.45M	-63.28%112.45M	-38.60%152.49M	-46.07%147.79M	-60.74%156.6M	-39.69%306.24M	-39.69%306.24M	21.80%248.34M	27.65%274.02M	72.73%398.86M
Free cash flow	40.37%-97.31M	61.14%-9.47M	35.98%-20.88M	31.14%-19.28M	39.04%-47.67M	-12.91%-163.2M	27.38%-24.38M	-37.98%-32.62M	-6.78%-28M	-27.98%-78.21M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall